# Prevention and Treatment of Stretch Marks With Stratamark™

> **NCT03377231** · PHASE4 · COMPLETED · sponsor: **Stratpharma AG** · enrollment: 272 (actual)

## Conditions studied

- Stretch Mark

## Interventions

- **DEVICE:** Stratamark®

## Key facts

- **NCT ID:** NCT03377231
- **Lead sponsor:** Stratpharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07-11
- **Primary completion:** 2016-05-16
- **Final completion:** 2016-05-16
- **Target enrollment:** 272 (ACTUAL)
- **Last updated:** 2017-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03377231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03377231, "Prevention and Treatment of Stretch Marks With Stratamark™". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03377231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*